America’s Recession-Proof Companies
With fears of a new economic downturn, investors have become concerned about sales and profits of large companies. But there are companies that have already proven themselves in the recent recession. They…
With fears of a new economic downturn, investors have become concerned about sales and profits of large companies. But there are companies that have already proven themselves in the recent recession. They…
Jon OggThese are some of this Thursday’s top analyst upgrades, downgrades, and initiations seen having an impact from Wall Street research calls. Amerisafe, Inc. (NASDAQ: AMSF) named Bear of the Day at…
Jon OggThese are some of this Monday’s top analyst upgrades, downgrades, and initiations seen having an impact from Wall Street research calls. Applied Materials Inc. (NASDAQ: AMAT) Cut to Sell at Goldman…
A new heart drug aimed a reducing the risk of strokes has outperformed the current drug of choice, warfarin, in a study that shows it lowers risk from a type of arrhythmia…
LG Display (NYSE: LPL) cuts capital expenditures as demand for LCD screens is hurt by tablet PC sales. (Reuters) Samsung to delay its tablet launch in the U.S. because of IP lawsuits…
Once patent protection expires on a prescription drug, the drug’s maker can take a serious beating in revenue and profitability. One way to make up for the loss is to get US…
Many drug companies face a what is called a patent cliff ahead, where the Big Pharma players will have key drugs go off-patent and there will be new generic competition. While this…
We may have just witnessed an oversold bounce in the stock market, or we may be in for more days of recovery. The markets are flirting with six weeks of negative performance…
Jon OggThese are some of the top analyst upgrades, downgrades, and initiations seen from Wall Street research calls this Wednesday morning. Aixtron SE (NASDAQ: AIXG) Cut to Sell at Canaccord Genuity. Bristol-Myers Squibb Company…
The fight against melanoma just got a new weapon after a drug called Yervoy, or ipilimumab, was given FDA approval for late-stage metastatic melanoma. The approval is a win for Bristol-Myers Squibb Company…
Earnings season may still be in force, but we are looking for the coming week’s top coming events that could have a large impact on shares on Monday and throughout the week. …
Dell’s (NASDAQ: DELL) margins rushed past expectations and shares moved higher (Reuters) Bernanke said a strong US recovery is essential to global economic health (Reuters) Lawmakers attacked regulators and banks on the…
Bristol-Myers Squibb (NYSE: BMY) will cut nearly 1,000 workers. That is on top of large rounds of firings in 2007 and 2008. The company gave an odd reason for the action.”The ultimate…
Reuters: Petrobras raised $70 billion in the largest stock offer in history. Reuters: There will likely be no tax cut before the election, according to Democrats Reuters: Obama asked the Chinese premier…
Reuters: Japan’s plan to intervene in yen trading has not moved the currency lower. Reuters: Oil dropped as investor moved away from risk Reuters: Hewlett-Packard (NYSE: HPQ) sued to keep Mark Hurd…